{
    "Trade/Device Name(s)": [
        "UCP Multi-Drug Test Key Cups"
    ],
    "Submitter Information": "UCP Biosciences, Inc.",
    "510(k) Number": "K132812",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130463"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIO",
        "DIS",
        "JXM",
        "DJC",
        "DJR",
        "DJG",
        "LCM",
        "LDJ",
        "LFG",
        "JXN"
    ],
    "Summary Letter Date": "February 18, 2014",
    "Summary Letter Received Date": "February 19, 2014",
    "Submission Date": "February 25, 2014",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3150",
        "21CFR862.3170",
        "21CFR862.3250",
        "21CFR862.3610",
        "21CFR862.3620"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Barbiturates",
        "Benzodiazepines",
        "Buprenorphine",
        "Cocaine",
        "Marijuana",
        "Methadone",
        "Methamphetamine",
        "MDMA",
        "Morphine",
        "Opiates 2000",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Tricyclic Antidepressant"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Competitive binding"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for UCP Multi-Drug Test Key Cups lateral flow immunochromatographic assays for qualitative detection of multiple drugs of abuse in urine.",
    "Indications for Use Summary": "Rapid, over-the-counter, preliminary detection of multiple drugs (including amphetamines, barbiturates, benzodiazepines, cocaine, marijuana, methadone, methamphetamine, MDMA, opiates, oxycodone, phencyclidine, propoxyphene, tricyclic antidepressants) in human urine, with confirmation testing recommended for preliminary positive results.",
    "fda_folder": "Toxicology"
}